A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB

NCT03530852 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Short Bowel Syndrome
Malabsorption

Interventions

DEVICE: Relizorb

Sponsor

Boston Children's Hospital

Collaborators

[object Object]